Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/18/26 20:56 | 2/17/26 | IVVD | Health | BioPrd | Biological Products, (No Diag | Allen Robert D. III | CT | O | Chief Sc | 2 | S.dm | -86 | 1.03 | 0 | -84 | 114 | D | |||||||||||||||
2/18/26 20:51 | 2/17/26 | IVVD | Health | BioPrd | Biological Products, (No Diag | Green Julie | CT | O | CHRO | 2 | S.dm | -93 | 1.03 | 0 | -90 | 108 | D | |||||||||||||||
2/18/26 20:49 | 2/17/26 | IVVD | Health | BioPrd | Biological Products, (No Diag | Duke William E. | CT | O | CFO | 2 | S.dm | -93 | 1.03 | 0 | -90 | 108 | D | |||||||||||||||
2/18/26 20:47 | 2/17/26 | IVVD | Health | BioPrd | Biological Products, (No Diag | Lee Timothy Edward | CT | O | Chief Co | 2 | S.dm | -93 | 1.03 | 0 | -90 | 118 | D | |||||||||||||||
2/18/26 20:47 | 2/17/26 | IVVD | Health | BioPrd | Biological Products, (No Diag | Andersen Jill | CT | O | GC,Secre | 2 | S.dm | -155 | 1.03 | 0 | -150 | 182 | D | |||||||||||||||
12/31/24 19:16 | 12/27/24 | IVVD | Health | BioPrd | Biological Products, (No Diag | McGuire Terrance | MA | D | 5 | S.m | -837 | 0.5162 | 0 | -1,621 | 7,934 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |